Literature DB >> 11396970

Specific binding of baculoviruses displaying gp64 fusion proteins to mammalian cells.

K Ojala1, D G Mottershead, A Suokko, C Oker-Blom.   

Abstract

Viral vectors displaying specific ligand binding moieties have raised an increasing interest in the area of targeted gene therapy. In this report, we describe baculovirus vectors displaying either a functional single chain antibody fragment (scFv) specific for the carcinoembryonic antigen (CEA) or the synthetic IgG binding domains (ZZ) derived from protein A of Staphylococcus aureus. In addition, the vectors were engineered to incorporate a reporter gene encoding the enhanced green fluorescent protein (EGFP) under the transcriptional regulation of the cytomegalovirus (CMV) IE promoter. Display of the targeting moieties on the viral surface was achieved through fusion to the N-terminus of gp64, the major envelope protein of the Autographa californica nuclear polyhedrosis virus (AcNPV). Specific binding of the gp64 fusion viruses to mammalian target cells was demonstrated by using monoclonal anti-gp64 antibodies followed by fluorescence and/or confocal microscopy. The anti-CEA scFv displaying baculovirus was shown to bind specifically to CEA expressing cells (PC-3). Similarly, the virus displaying the ZZ domains of protein A was targeted to BHK cells via binding of an appropriate IgG antibody. In all cases, the reporter gene was expressed in the transduced mammalian cells as shown by fluorescence microscopy and flow cytometric analyses. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11396970     DOI: 10.1006/bbrc.2001.5048

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Cell targeting with hybrid Qβ virus-like particles displaying epidermal growth factor.

Authors:  Jonathan K Pokorski; Marisa L Hovlid; M G Finn
Journal:  Chembiochem       Date:  2011-09-29       Impact factor: 3.164

2.  Baculovirus entry into human hepatoma cells.

Authors:  Heli Matilainen; Johanna Rinne; Leona Gilbert; Varpu Marjomäki; Hilkka Reunanen; Christian Oker-Blom
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Baculovirus display of functional antibody Fab fragments.

Authors:  Shinya Takada; Takafumi Ogawa; Kazusa Matsui; Tasuku Suzuki; Tomohisa Katsuda; Hideki Yamaji
Journal:  Cytotechnology       Date:  2015-04-24       Impact factor: 2.058

4.  Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides.

Authors:  Anna R Mäkelä; Heli Matilainen; Daniel J White; Erkki Ruoslahti; Christian Oker-Blom
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses.

Authors:  Yoshinori Kitagawa; Hideki Tani; Chang Kwang Limn; Tomoko M Matsunaga; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  The Major Hurdle for Effective Baculovirus Transduction into Mammalian Cells Is Passing Early Endosomes.

Authors:  Liangbo Hu; Yimeng Li; Yun-Jia Ning; Fei Deng; Just M Vlak; Zhihong Hu; Hualin Wang; Manli Wang
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

Review 7.  Genetic modification of baculovirus expression vectors.

Authors:  Shu-fen Li; Hua-lin Wang; Zhi-hong Hu; Fei Deng
Journal:  Virol Sin       Date:  2012-04-11       Impact factor: 4.327

8.  The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteins.

Authors:  A G P Oomens; Gail W Wertz
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Baculovirus display of single chain antibody (scFv) using a novel signal peptide.

Authors:  Kuntida Kitidee; Sawitree Nangola; Gaëlle Gonzalez; Pierre Boulanger; Chatchai Tayapiwatana; Saw-See Hong
Journal:  BMC Biotechnol       Date:  2010-11-19       Impact factor: 2.563

10.  Antibody-mediated targeting of an adenovirus vector modified to contain a synthetic immunoglobulin g-binding domain in the capsid.

Authors:  Christoph Volpers; Christian Thirion; Volker Biermann; Stefanie Hussmann; Helmut Kewes; Patrick Dunant; Helga von der Mark; Andreas Herrmann; Stefan Kochanek; Hanns Lochmüller
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.